Clinical Benefit of Topoisomerase Downregulation

计划入组 15 人 · 首次发布于 2005 年 11 月 7 日

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

计划入组 40 人 · 首次发布于 2026 年 2 月 18 日

Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin

计划入组 338 人 · 首次发布于 2005 年 9 月 13 日

AF-1

GYR-777 series (Biota)

GYR-767 series (Aviragen Therapeutics)

Heart Hospital IV, L.P.

United States

Ligand Pharmaceuticals

United States

Outlook Therapeutics

United States

Novel Antibiotic Gepotidacin Shows Promise for Drug-Resistant UTIs, Awaits FDA Review

BWC0977: A Novel Antibacterial Agent Shows Promise Against Multi-Drug Resistant Infections

New Oral Antibiotics Show Promise Against Drug-Resistant Gonorrhea